Comprehensive treatment for all melanomas

Specialists at Penn Medicine use advanced imaging and surgical technology to treat all kinds of melanomas. This includes melanoma of the skin, ocular (eye) melanoma, mucosal melanoma, and melanoma that has metastasized or spread.

Treating melanoma effectively requires exceptional expertise and specialized training. When you come to Penn Medicine, you’re in expert hands: our melanoma specialists have years of experience treating even the most complex melanoma cases. Your care team with our Melanoma and Skin Cancer Care program includes surgeons, doctors, radiologists, and other experienced providers.

How melanoma treatment is determined

Treatment for melanoma is chosen based on several factors.

  • Whether the melanoma has spread: Your provider evaluates the tumor’s size, depth, and potential spread to other parts of the body.
  • Location of the melanoma: Skin melanomas may be treated differently from melanoma of the eye or melanoma of the mucous membranes.
  • Your health: Age, presence of other medical conditions, and previous treatments may affect the choice of treatment.
  • Genetic factors: Some melanomas may have specific genetic mutations. Targeted therapy drugs may be used to focus on these mutations.
  • Your preferences: Our experts ensure you have a clear understanding of treatment details, potential side effects, and the impact on your quality of life. They prioritize your preferences when crafting treatment plans.
  • Multidisciplinary team consultation: Treatment decisions are often made by a team of experts involved in your care, including surgeons, oncologists, dermatologists, and other specialists.

Nationally recognized program dedicated to melanoma care

The Penn Medicine Tara Miller Melanoma Center, located at the Perelman Center for Advanced Medicine in Philadelphia, is designed to provide advanced care for people with all types of melanomas. Our doctors have years of specialized training and work together to diagnose and treat rare, complex melanomas that would previously have been considered untreatable. They collaborate with other providers across the community to ensure all patients have access to advanced melanoma care close to home.

In addition, the National Cancer Institute (NCI) has recognized the Tara Miller Melanoma Center as outstanding. Earning the NCI’s highest rating for cancer research shows our commitment to bringing new discoveries directly to your care. Our providers put you first to give you the best possible care and offer support to you and your family members.

National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.